Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biphasic Elimination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biphasic elimination method for 16-dehydroprogesterone manufacturing. Enhances purity and reduces costs for global pharmaceutical supply chains effectively.
Patent CN114133364B reveals a green synthesis for oseltamivir intermediates using biphasic catalysis, offering high purity and reduced manufacturing costs for global supply chains.
Novel elimination method for high-purity 16-dehydroprogesterone. Cost-effective, scalable process for steroid drug manufacturing utilizing biphasic catalysis.